The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow

In the retina, hypoxic condition leads to overgrowing leaky vessels resulting in altered metabolic supply that may cause impaired visual function. Hypoxia-inducible factor-1 (HIF-1) is a central regulator of the retinal response to hypoxia by activating the transcription of numerous target genes, in...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Maurizio Cammalleri, Rosario Amato, Massimo Dal Monte, Luca Filippi, Paola Bagnoli
Формат: Өгүүллэг
Хэл сонгох:English
Хэвлэсэн: Elsevier 2023-04-01
Цуврал:Pharmacological Research
Нөхцлүүд:
Онлайн хандалт:http://www.sciencedirect.com/science/article/pii/S1043661823000695
_version_ 1827630375502872576
author Maurizio Cammalleri
Rosario Amato
Massimo Dal Monte
Luca Filippi
Paola Bagnoli
author_facet Maurizio Cammalleri
Rosario Amato
Massimo Dal Monte
Luca Filippi
Paola Bagnoli
author_sort Maurizio Cammalleri
collection DOAJ
description In the retina, hypoxic condition leads to overgrowing leaky vessels resulting in altered metabolic supply that may cause impaired visual function. Hypoxia-inducible factor-1 (HIF-1) is a central regulator of the retinal response to hypoxia by activating the transcription of numerous target genes, including vascular endothelium growth factor, which acts as a major player in retinal angiogenesis. In the present review, oxygen urge by the retina and its oxygen sensing systems including HIF-1 are discussed in respect to the role of the beta-adrenergic receptors (β-ARs) and their pharmacologic manipulation in the vascular response to hypoxia. In the β-AR family, β1- and β2-AR have long been attracting attention because their pharmacology is intensely used for human health, while β3-AR, the third and last cloned receptor is no longer increasingly emerging as an attractive target for drug discovery. Here, β3-AR, a main character in several organs including the heart, the adipose tissue and the urinary bladder, but so far a supporting actor in the retina, has been thoroughly examined in respect to its function in retinal response to hypoxia. In particular, its oxygen dependence has been taken as a key indicator of β3-AR involvement in HIF-1-mediated responses to oxygen. Hence, the possibility of β3-AR transcription by HIF-1 has been discussed from early circumstantial evidence to the recent demonstration that β3-AR acts as a novel HIF-1 target gene by playing like a putative intermediary between oxygen levels and retinal vessel proliferation. Thus, targeting β3-AR may implement the therapeutic armamentarium against neovascular pathologies of the eye.
first_indexed 2024-03-09T14:05:57Z
format Article
id doaj.art-800e08a52f0644f793005cdde2fef478
institution Directory Open Access Journal
issn 1096-1186
language English
last_indexed 2024-03-09T14:05:57Z
publishDate 2023-04-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj.art-800e08a52f0644f793005cdde2fef4782023-11-30T05:05:54ZengElsevierPharmacological Research1096-11862023-04-01190106713The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadowMaurizio Cammalleri0Rosario Amato1Massimo Dal Monte2Luca Filippi3Paola Bagnoli4Department of Biology, University of Pisa, Pisa, Italy; Correspondence to: Department of Biology, University of Pisa, via San Zeno 31, 56127 Pisa, Italy.Department of Biology, University of Pisa, Pisa, ItalyDepartment of Biology, University of Pisa, Pisa, ItalyDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyDepartment of Biology, University of Pisa, Pisa, Italy; Correspondence to: Department of Biology, University of Pisa, via San Zeno 31, 56127 Pisa, Italy.In the retina, hypoxic condition leads to overgrowing leaky vessels resulting in altered metabolic supply that may cause impaired visual function. Hypoxia-inducible factor-1 (HIF-1) is a central regulator of the retinal response to hypoxia by activating the transcription of numerous target genes, including vascular endothelium growth factor, which acts as a major player in retinal angiogenesis. In the present review, oxygen urge by the retina and its oxygen sensing systems including HIF-1 are discussed in respect to the role of the beta-adrenergic receptors (β-ARs) and their pharmacologic manipulation in the vascular response to hypoxia. In the β-AR family, β1- and β2-AR have long been attracting attention because their pharmacology is intensely used for human health, while β3-AR, the third and last cloned receptor is no longer increasingly emerging as an attractive target for drug discovery. Here, β3-AR, a main character in several organs including the heart, the adipose tissue and the urinary bladder, but so far a supporting actor in the retina, has been thoroughly examined in respect to its function in retinal response to hypoxia. In particular, its oxygen dependence has been taken as a key indicator of β3-AR involvement in HIF-1-mediated responses to oxygen. Hence, the possibility of β3-AR transcription by HIF-1 has been discussed from early circumstantial evidence to the recent demonstration that β3-AR acts as a novel HIF-1 target gene by playing like a putative intermediary between oxygen levels and retinal vessel proliferation. Thus, targeting β3-AR may implement the therapeutic armamentarium against neovascular pathologies of the eye.http://www.sciencedirect.com/science/article/pii/S1043661823000695Oxygen tensionHIF-1/VEGF axisHIF-1 target geneβ-AR pharmacologyDrug targetingOxygen-induced retinopathy
spellingShingle Maurizio Cammalleri
Rosario Amato
Massimo Dal Monte
Luca Filippi
Paola Bagnoli
The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow
Pharmacological Research
Oxygen tension
HIF-1/VEGF axis
HIF-1 target gene
β-AR pharmacology
Drug targeting
Oxygen-induced retinopathy
title The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow
title_full The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow
title_fullStr The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow
title_full_unstemmed The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow
title_short The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow
title_sort β3 adrenoceptor in proliferative retinopathies cinderella steps out of its family shadow
topic Oxygen tension
HIF-1/VEGF axis
HIF-1 target gene
β-AR pharmacology
Drug targeting
Oxygen-induced retinopathy
url http://www.sciencedirect.com/science/article/pii/S1043661823000695
work_keys_str_mv AT mauriziocammalleri theb3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow
AT rosarioamato theb3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow
AT massimodalmonte theb3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow
AT lucafilippi theb3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow
AT paolabagnoli theb3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow
AT mauriziocammalleri b3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow
AT rosarioamato b3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow
AT massimodalmonte b3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow
AT lucafilippi b3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow
AT paolabagnoli b3adrenoceptorinproliferativeretinopathiescinderellastepsoutofitsfamilyshadow